Patent details

EP1797892 Title: Use of modified cyclosporins for the treatment of HCV disorders

Basic Information

Publication number:
EP1797892
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP061256491
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of modified cyclosporins for the treatment of HCV disorders
French Title of Invention:
Utilisation de cyclosporines modifiées pour le traitement de maladies liées au virus de l'hépatite C (HCV)
German Title of Invention:
Verwendung von modifizierten Cyclosporinen zur Behandlung von HCV Krankheiten
SPC Number:

Dates

Filing date:
02/09/2004
Grant date:
23/10/2013
EP Publication Date:
23/10/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/06/2007
EP B1 Publication Date:
23/10/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/09/2014
Expiration date:
02/09/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/09/2004
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:
Shimotohno Kunitada
Address:
Japan (JP)

2

Name:
Watashi Koichi
Address:
Japan (JP)

3

Name:
Hijikata Makoto
Address:
Japan (JP)

Priority

Priority Number:
0320638
Priority Date:
03/09/2003
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 38/13;
Filing date Document type Number of pages